Scholarly article on Cyclohexanone, 3-(1-ethyl-1-butenyl)-, (E)- 64955-02-8 from Journal of the American Chemical Society p. 8045 - 8046

DOI: 10.1021/ja00466a044

Source and publish data:

Journal of the American Chemical Society p. 8045 - 8046 (1977)

Update date:2022-08-04

Topics:

Authors:

Loots,M.J.

Schwartz,J.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00466a044

Full text of DOI:10.1021/ja00466a044

Products guided by the article

Product name:Cyclohexanone, 3-(1-ethyl-1-butenyl)-, (E)-

Cas No:64955-02-8

R&D Labs maybe for 64955-02-8

Taizhou Elitechemie MediPharma Technology Co.,Ltd.

Contact:+86-523-86810021

Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
SHIJIAZHUANG CHENSHI IMPORT AND EXPORT CO.,LTD

Contact:+86-311-89871056

Address:RM2017 BUILDING CTIANSHAN GALAXY PLAZA,NO168 CHANGJIANG ROAD,GAOXIN DISTRICT,SHIJIAZHUANG CITY, HEBEI,CHINA
Chengdu Sino-Strong Pharmaceutical Co.,Ltd.

website:http://www.sino-strong.com.cn

Contact:+86-28-82666753

Address:459 West haike road,Cross-straits technological industry park, Wenjiang district,Chengdu, P.R.China
ZHEJIANG SYNOSE TECH CO.,LTD.

website:https://www.synose.com/

Contact:86-579-82275537

Address:No.1958 Liyu Road , jinhua,zhejiang,China
Shanghai Hongbang Medical Technology CO.,. Ltd

Contact:13671516988 /18917636693

Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.

Relevant to this article

The use of 4-(3,4-dichlorophenyl)-4-oxo-2-(4-antipyrinyl)-butanoic acid in the preparation of some new heterocyclic compounds with expected biological activity

Doi:10.3390/80300322
(2003)
Doi:10.1139/v58-206
(1958)
Doi:10.1016/S0040-4039(01)83737-0
(1977)
Crystal structure as the basis for the lack of enantiotropic mesomorphism in 3-hydroxy-4-propionylphenyl-4′-n-alkyloxybenzoates

Doi:10.1134/S0018143916060114
(2016)
Doi:10.1021/ja01220a012
(1945)
Heterocyclic thrombin inhibitors. Part 2: Quinoxalinone derivatives as novel, potent antithrombotic agents

Doi:10.1016/S0960-894X(03)00443-8
(2003)

Article Doi

DOI: 10.1021/ja00466a044